LIQUIDITY	3 Months Ended
Mar. 31, 2024
LIQUIDITY
LIQUIDITY	NOTE 2 - LIQUIDITY: At March 31, 2024 and December 31, 2023, the Company had cash and cash equivalents of $351,388 and $388,171, respectively, consisting of money market funds and U.S. Treasury Bills. Our net losses incurred for the three months ended March 31, 2024 and 2023, amounted to $35,271 and $635,296, respectively, and we had working capital of $347,915 and $383,186 at March 31, 2024 and December 31, 2023, respectively. Management believes that its cash and cash equivalents are sufficient for its business activities for at least the next twelve months and for the costs of seeking an acquisition of an operating business.

LIQUIDITY

3 Months Ended

Mar. 31, 2024

NOTE 2 - LIQUIDITY:

At March 31, 2024 and December 31, 2023, the Company had cash and cash equivalents of $351,388 and $388,171, respectively, consisting of money market funds and U.S. Treasury Bills. Our net losses incurred for the three months ended March 31, 2024 and 2023, amounted to $35,271 and $635,296, respectively, and we had working capital of $347,915 and $383,186 at March 31, 2024 and December 31, 2023, respectively. Management believes that its cash and cash equivalents are sufficient for its business activities for at least the next twelve months and for the costs of seeking an acquisition of an operating business.